Logo

Abbott

Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales

The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent. 

JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Agilent, Roche, Seer, More

Highlights from the second day included Agilent's $725 million investment in nucleic acids manufacturing and Roche's development plans for an integrated mass spec platform.

Abbott Q3 Diagnostics Revenues Fall 6 Percent Due to COVID-19 Testing Decline
Premium

The firm's core laboratory revenues fell 6 percent, while molecular sales were down 47 percent.

Abbott Gets FDA Emergency Use Authorization for Monkeypox PCR Test

The FDA granted authorization for the Alinity m MPXV assay, Abbott's real-time PCR test using human lesion swab specimens.

In Brief This Week: Thermo Fisher Scientific, DNAnexus, Precipio, Delfi Diagnostics, Streck, More

News items for the week of Sept. 12, 2022.

Jul 20, 2022

Continued COVID-19 Test Demand Lifts Abbott Q2 Dx Revenues up 33 Percent
Premium

May 16, 2022

Abbott Gets FDA Emergency Use Authorization for Point-of-Care COVID-19 Test

May 4, 2022

Abbott Nabs FDA Clearance for Multiplex Molecular STI Panel

Apr 22, 2022

Nutromics Eyes Clinical Applications for Electrochemical Continuous Molecular Monitoring Platform
Premium

Apr 20, 2022

Abbott Focusing on Base Business Recovery, but COVID-19 Testing Remains Crucial Revenue Source
Premium

Apr 20, 2022

Abbott Q1 Diagnostics Revenues Climb 32 Percent

Apr 6, 2022

As COVID-19 Sales Retreat, Diagnostic Firms Turn Attention to Core Businesses
Premium

Jan 27, 2022

Abbott Preparing for COVID-19 Testing Uncertainty in 2022
Premium

Jan 26, 2022

Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent

Jan 12, 2022

JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More

Dec 10, 2021

People in the News: New Appointments at NIH, Abbott, Talis Biomedical, More

Oct 21, 2021

Abbott Sees Continued Demand for SARS-CoV-2 Rapid Tests Despite Expected Decline in Cases
Premium

Oct 20, 2021

Abbott Q3 Diagnostics Revenues Rise 48 Percent on Core Lab, Rapid Diagnostics Sales Growth

Oct 14, 2021

FDA Classifies Abbott SARS-CoV-2 Molecular Test Recall as Class I Due to False Positives

Sep 17, 2021

FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests

Jul 22, 2021

Abbott Q2 Diagnostics Revenues Rise 63 Percent on COVID-19 Testing Demand

Jun 1, 2021

Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue

Apr 20, 2021

Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing

Mar 11, 2021

Abbott Forms Global Coalition to Monitor, Prevent Future Pandemics

Mar 5, 2021

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.